Impact of APOE4‐related dementia risk in underrepresented groups from the All of Us research program
Authors:
Open Access
- 11 June 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (6) , e70245
Abstract
INTRODUCTION: Longitudinal electronic health records (EHRs), “dementia” diagnostic codes, and genetic data from All of Us were used to see if there is a higher risk of dementia and an attenuated impact of apolipoprotein ε4 (APOE4) on Alzheimer's disease (AD) risk in Black and Hispanic/Latino groups.METHODS: Participants included 9,784 Hispanic/Latinos, 14,937 Non‐Hispanic Blacks (NHB), and 60,388 Non‐Hispanic Whites (NHWs) ≥age 60 without an initial dementia diagnosis.RESULTS: There was a significantly higher risk of developing a dementia diagnosis in Hispanic/Latino and NHB participants than NHW participants and comparably increased dementia hazard ratios in the Hispanic/Latino, NHB, and NHW APOE4 carriers than non‐carriers (hazard ratio [HR] [95% confidence interval {CI}] 1.54 [1.25–1.91], 1.25 [1.00–1.57], and 1.55 [1.40–1.72]).DISCUSSION: Compared to NHW individuals, Hispanic/Latino and NHB individuals are at higher risk of developing a “dementia diagnosis” and comparably higher risk in APOE4 carriers than non‐carriers. Plasma AD biomarkers could clarify the proportion of dementia cases with and without AD and the impact of APOE4 on AD in these groups.Highlights: Hispanic/Latino and non‐Hispanic Black individuals have a higher risk of all‐cause dementia. The impact of apolipoprotein ε4 (APOE4) on dementia risk was similar in the studied ethnoracial groups. Plasma biomarkers could inform the risk of Alzheimer's disease (AD) and impact of APOE4 in these groups.Keywords
Funding Information
- Office of the Director
This publication has 44 references indexed in Scilit:
- Life-Course Socioeconomic Position and Incidence of Dementia and Cognitive Impairment Without Dementia in Older Mexican Americans: Results From the Sacramento Area Latino Study on AgingAmerican Journal of Epidemiology, 2011
- Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methodsBritish Journal of Cancer, 2003
- Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotypeJournal of the International Neuropsychological Society, 2002
- What is cognitive reserve? Theory and research application of the reserve conceptJournal of the International Neuropsychological Society, 2002
- Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.Psychology and Aging, 1999
- The APOE-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and HispanicsJAMA, 1998
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.1997
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseNature Genetics, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993